1999-00-4 | ethyl 3-(4-fluorophenyl)-3-oxopropanoate

Packsize	Purity	Availability	Price	Discounted Price
1g	96%	in stock	$11.00	$8.00
5g	96%	in stock	$14.00	$10.00
10g	96%	in stock	$21.00	$15.00
25g	96%	in stock	$52.00	$36.00
100g	96%	in stock	$204.00	$143.00

Description

• Catalog Number: AB09224
• Chemical Name: ethyl 3-(4-fluorophenyl)-3-oxopropanoate
• CAS Number: 1999-00-4
• Molecular Formula: C11H11FO3
• Molecular Weight: 210.2016
• MDL Number: MFCD03093631
• SMILES: CCOC(=O)CC(=O)c1ccc(cc1)F

Computed Properties

• Complexity: 232
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 15
• Hydrogen Bond Acceptor Count: 4
• Rotatable Bond Count: 5
• XLogP3: 2

Literature

• Genital ulcer disease treatment for reducing sexual acquisition of HIV.

  The Cochrane database of systematic reviews 20120815

• Mass spectrometic study of speciation in aluminium-fluoroquinolone solutions.

  European journal of mass spectrometry (Chichester, England) 20120101

• Air- and heat-stable planar tri-p-quinodimethane with distinct biradical characteristics.

  Journal of the American Chemical Society 20111019

• Photodegradation of fleroxacin injection: different products with different concentration levels.

  AAPS PharmSciTech 20110901

• Synergistic antitumor effects of fleroxacin with 5-fluorouracil in vitro and in vivo for bladder cancer cell lines.

  Urology 20091201

• Inter- and intramolecular photochemical reactions of fleroxacin.

  Organic letters 20090507

• Enhanced separation of seven quinolones by capillary electrophoresis with silica nanoparticles as additive.

  Talanta 20090315

• Capillary electrophoresis with electrochemiluminescence detection for simultaneous determination of proline and fleroxacin in human urine.

  Drug testing and analysis 20090201

• Quantitative comparison of the convulsive activity of combinations of twelve fluoroquinolones with five nonsteroidal antiinflammatory agents.

  Drug metabolism and pharmacokinetics 20090101

• A rapid CE-potential gradient detection method for determination of quinolones.

  Electrophoresis 20071101

• 1H and 19F NMR relaxation studies of fleroxacin with Micrococcus luteus.

  Journal of pharmaceutical and biomedical analysis 20070411

• [Study on the ternary complex of FLRX, zinc(II) and BSA by the method of fluorescence].

  Guang pu xue yu guang pu fen xi = Guang pu 20070401

• [Clinical observation on shufei granule in improving right ventricular function of patients with chronic pulmonary heart disease].

  Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20060801

• [Determination of fleroxacin by photochemical fluorescence of zinc-fleroxacin complex].

  Guang pu xue yu guang pu fen xi = Guang pu 20050901

• Synthesis and antibacterial activity of 1-(2-fluorovinyl)-7-substituted-4-quinolone-3-carboxylic acid derivatives, conformationally restricted analogues of fleroxacin.

  Journal of medicinal chemistry 20050505

• [Ultraviolet spectral characteristics of charge-transfer reaction complex in micellar system and its application].

  Guang pu xue yu guang pu fen xi = Guang pu 20050201

• A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20041101

• Validation of an HPLC method for the determination of fleroxacin and its photo-degradation products in pharmaceutical forms.

  Annali di chimica 20040101

• [Fluorescence spectrometric determination of fleroxacin by charge-transfer reaction].

  Guang pu xue yu guang pu fen xi = Guang pu 20030401

• Inhibition by fluoroquinolones of K(+) currents in rat dissociated hippocampal neurons.

  European journal of pharmacology 20030221

• Determination of fleroxacin in pure and tablet forms by liquid chromatography and derivative UV-spectrophotometry.

  Journal of AOAC International 20030101

• Influence of sex on the pharmacokinetic interaction of fleroxacin and ciprofloxacin with caffeine.

  Clinical pharmacokinetics 20030101

• [In vitro antibacterial activity of prulifloxacin, a new oral fluoroquinolone].

  The Japanese journal of antibiotics 20021201

• A pilot study of oral fleroxacin once daily compared with conventional therapy in patients with pyogenic liver abscess.

  Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 20020901

• [Drug interactions between nonsteroidal anti-inflammatory drug and pazufloxacin mesilate, a new quinolone antibacterial agent for intravenous use: convulsions in mice after intravenous or intracerebroventricular administration].

  The Japanese journal of antibiotics 20020601

• Protective effect of fleroxacin against the nephrotoxicity of isepamicin in rats.

  Biological & pharmaceutical bulletin 20020401

• Ultrastructure of Achilles tendon from rats after treatment with fleroxacin.

  Archives of toxicology 20010401

• Effects of fluoroquinolones on the locomotor activity in rats.

  Archives of toxicology 20010301

• Spectrophotometric and HPLC determination of fleroxacin in tablets.

  Die Pharmazie 20010201

• Fleroxacin uptake in ischaemic limb tissue.

  Acta microbiologica et immunologica Hungarica 20010101

• [Encephalopathy induced by fleroxacin in a patient with Machado-Joseph disease].

  Rinsho shinkeigaku = Clinical neurology 19980901

• Atypical pneumonia in the Nordic countries: aetiology and clinical results of a trial comparing fleroxacin and doxycycline. Nordic Atypical Pneumonia Study Group.

  The Journal of antimicrobial chemotherapy 19970401

• Fleroxacin 400 mg once daily versus ofloxacin 400 mg twice daily in skin and soft tissue infections.

  Chemotherapy 19970101

• Two cases of fleroxacin-induced insomnia.

  International clinical psychopharmacology 19940101

• Activity of topoisomerase inhibitors against Pneumocystis carinii in vitro and in an inoculated mouse model.

  Antimicrobial agents and chemotherapy 19930701

• Comparative in vitro and in vivo activity of fleroxacin and ofloxacin against various mycobacteria.

  Tubercle 19910901

• Central nervous system toxicity of quinolones: human and animal findings.

  The Journal of antimicrobial chemotherapy 19901001

• The antimicrobial activity of Fleroxacin RO 23-6240, a third generation fluoroquinolone derivative, tested in vitro.

  Journal of hygiene, epidemiology, microbiology, and immunology 19900101

• Adverse reactions in a dose-ranging study with a new long-acting fluoroquinolone, fleroxacin.

  Antimicrobial agents and chemotherapy 19891001

• Comparative in-vitro activity of fleroxacin and other 6-fluoroquinolones against mycobacteria.

  The Journal of antimicrobial chemotherapy 19881001